Logo image of ECCF

EAGLE POINT CREDIT CO - ECC 8 01/31/29 (ECCF) Stock Fundamental Analysis

NYSE:ECCF - New York Stock Exchange, Inc. - US2698098777 - Currency: USD

25.185  +0.14 (+0.58%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ECCF. ECCF was compared to 0 industry peers in the Unkown industry. ECCF has a bad profitability rating. Also its financial health evaluation is rather negative. ECCF is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ECCF was profitable.
ECCF had a negative operating cash flow in the past year.
Of the past 5 years ECCF 4 years were profitable.
In the past 5 years ECCF reported 4 times negative operating cash flow.
ECCF Yearly Net Income VS EBIT VS OCF VS FCFECCF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M -400M

1.2 Ratios

Industry RankSector Rank
ROA -3.6%
ROE -5.15%
ROIC 6.48%
ROA(3y)1.32%
ROA(5y)6.59%
ROE(3y)1.24%
ROE(5y)9.12%
ROIC(3y)6.93%
ROIC(5y)6.24%
ECCF Yearly ROA, ROE, ROICECCF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

In the last couple of years the Profit Margin of ECCF has declined.
ECCF's Operating Margin has improved in the last couple of years.
In the last couple of years the Gross Margin of ECCF has grown nicely.
Industry RankSector Rank
OM 60.46%
PM (TTM) N/A
GM 63.17%
OM growth 3Y5.72%
OM growth 5Y2.96%
PM growth 3Y-33.04%
PM growth 5YN/A
GM growth 3Y3%
GM growth 5Y2.17%
ECCF Yearly Profit, Operating, Gross MarginsECCF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

3

2. Health

2.1 Basic Checks

ECCF has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ECCF has been increased compared to 5 years ago.
ECCF has a worse debt/assets ratio than last year.
ECCF Yearly Shares OutstandingECCF Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ECCF Yearly Total Debt VS Total AssetsECCF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

ECCF has an Altman-Z score of 4.13. This indicates that ECCF is financially healthy and has little risk of bankruptcy at the moment.
ECCF has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 4.13
ROIC/WACCN/A
WACCN/A
ECCF Yearly LT Debt VS Equity VS FCFECCF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 2.22 indicates that ECCF has no problem at all paying its short term obligations.
ECCF has a Quick Ratio of 2.22. This indicates that ECCF is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.22
Quick Ratio 2.22
ECCF Yearly Current Assets VS Current LiabilitesECCF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

5

3. Growth

3.1 Past

The earnings per share for ECCF have decreased strongly by -22.73% in the last year.
The Earnings Per Share has been decreasing by -2.24% on average over the past years.
ECCF shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.26%.
Measured over the past years, ECCF shows a very strong growth in Revenue. The Revenue has been growing by 22.03% on average per year.
EPS 1Y (TTM)-22.73%
EPS 3Y-5.35%
EPS 5Y-2.24%
EPS Q2Q%-35.29%
Revenue 1Y (TTM)29.26%
Revenue growth 3Y26.64%
Revenue growth 5Y22.03%
Sales Q2Q%14.54%

3.2 Future

The Earnings Per Share is expected to decrease by -9.64% on average over the next years.
ECCF is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.22% yearly.
EPS Next Y-12.57%
EPS Next 2Y-9.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.04%
Revenue Next 2Y16.22%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ECCF Yearly Revenue VS EstimatesECCF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ECCF Yearly EPS VS EstimatesECCF Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 24.69 indicates a rather expensive valuation of ECCF.
Compared to an average S&P500 Price/Earnings ratio of 26.73, ECCF is valued at the same level.
The Price/Forward Earnings ratio is 26.36, which means the current valuation is very expensive for ECCF.
ECCF's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 34.61.
Industry RankSector Rank
PE 24.69
Fwd PE 26.36
ECCF Price Earnings VS Forward Price EarningsECCF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ECCF Per share dataECCF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

ECCF's earnings are expected to decrease with -9.64% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.64%
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.99%, ECCF is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.39, ECCF pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.99%

5.2 History

ECCF is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ECCF Yearly Dividends per shareECCF Yearly Dividends per shareYearly Dividends per share 2024 2025 0.5 1 1.5 2

5.3 Sustainability

ECCF has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-326.46%
EPS Next 2Y-9.64%
EPS Next 3YN/A
ECCF Yearly Income VS Free CF VS DividendECCF Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M -400M

EAGLE POINT CREDIT CO - ECC 8 01/31/29

NYSE:ECCF (8/13/2025, 1:21:02 PM)

25.185

+0.14 (+0.58%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-12 2025-08-12/bmo
Earnings (Next)11-12 2025-11-12/bmo
Inst Owners8.61%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap3.03B
Analysts77.78
Price Target30.39 (20.67%)
Short Float %0%
Short Ratio0.18
Dividend
Industry RankSector Rank
Dividend Yield 7.99%
Yearly Dividend1.74
Dividend Growth(5Y)N/A
DP-326.46%
Div Incr Years0
Div Non Decr Years0
Ex-Date12-11 2025-12-11 (0.166667)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.14%
Min EPS beat(2)-13.9%
Max EPS beat(2)3.62%
EPS beat(4)2
Avg EPS beat(4)-5.6%
Min EPS beat(4)-13.9%
Max EPS beat(4)3.62%
EPS beat(8)3
Avg EPS beat(8)-6.78%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.13%
Min Revenue beat(2)-1.41%
Max Revenue beat(2)-0.85%
Revenue beat(4)1
Avg Revenue beat(4)-1.27%
Min Revenue beat(4)-6.65%
Max Revenue beat(4)3.83%
Revenue beat(8)3
Avg Revenue beat(8)-1.05%
Revenue beat(12)6
Avg Revenue beat(12)-1.21%
Revenue beat(16)9
Avg Revenue beat(16)0.08%
PT rev (1m)10.05%
PT rev (3m)2.13%
EPS NQ rev (1m)-0.81%
EPS NQ rev (3m)-4.65%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.99%
Revenue NQ rev (1m)-0.55%
Revenue NQ rev (3m)-0.65%
Revenue NY rev (1m)-0.63%
Revenue NY rev (3m)-0.53%
Valuation
Industry RankSector Rank
PE 24.69
Fwd PE 26.36
P/S 15.85
P/FCF N/A
P/OCF N/A
P/B 2.97
P/tB 2.97
EV/EBITDA N/A
EPS(TTM)1.02
EY4.05%
EPS(NY)0.96
Fwd EY3.79%
FCF(TTM)-3.37
FCFYN/A
OCF(TTM)-3.37
OCFYN/A
SpS1.59
BVpS8.47
TBVpS8.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.6%
ROE -5.15%
ROCE 8.2%
ROIC 6.48%
ROICexc 6.48%
ROICexgc 6.48%
OM 60.46%
PM (TTM) N/A
GM 63.17%
FCFM N/A
ROA(3y)1.32%
ROA(5y)6.59%
ROE(3y)1.24%
ROE(5y)9.12%
ROIC(3y)6.93%
ROIC(5y)6.24%
ROICexc(3y)7.33%
ROICexc(5y)6.51%
ROICexgc(3y)7.34%
ROICexgc(5y)6.51%
ROCE(3y)8.78%
ROCE(5y)7.89%
ROICexcg growth 3Y7.57%
ROICexcg growth 5Y-0.43%
ROICexc growth 3Y7.47%
ROICexc growth 5Y-0.49%
OM growth 3Y5.72%
OM growth 5Y2.96%
PM growth 3Y-33.04%
PM growth 5YN/A
GM growth 3Y3%
GM growth 5Y2.17%
F-Score0
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 5.48
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.22
Quick Ratio 2.22
Altman-Z 4.13
F-Score0
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.73%
EPS 3Y-5.35%
EPS 5Y-2.24%
EPS Q2Q%-35.29%
EPS Next Y-12.57%
EPS Next 2Y-9.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)29.26%
Revenue growth 3Y26.64%
Revenue growth 5Y22.03%
Sales Q2Q%14.54%
Revenue Next Year22.04%
Revenue Next 2Y16.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.8%
EBIT growth 3Y33.88%
EBIT growth 5Y25.64%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-531.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-531.18%
OCF growth 3YN/A
OCF growth 5YN/A